Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.26 million shares were traded. GUTS stock price reached its highest trading level at $1.27 during the session, while it also had its lowest trading level at $1.2101.
Ratios:
For a deeper understanding of Fractyl Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 15, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On August 28, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $3.60.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 162598352 and an Enterprise Value of 101282488. For the stock, the TTM Price-to-Sale (P/S) ratio is 8130.00. Its current Enterprise Value per Revenue stands at 5957.793 whereas that against EBITDA is -1.025.
Stock Price History:
The Beta on a monthly basis for GUTS is 2.24, which has changed by -0.51953125 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $3.38, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 3.82%, while the 200-Day Moving Average is calculated to be -15.89%.
Shares Statistics:
For the past three months, GUTS has traded an average of 3.08M shares per day and 1184670 over the past ten days. A total of 132.19M shares are outstanding, with a floating share count of 108.69M. Insiders hold about 17.78% of the company’s shares, while institutions hold 14.41% stake in the company. Shares short for GUTS as of 1760486400 were 6852307 with a Short Ratio of 2.22, compared to 1757894400 on 1692350. Therefore, it implies a Short% of Shares Outstanding of 6852307 and a Short% of Float of 6.0700003.
Earnings Estimates
Fractyl Health Inc (GUTS) is presently subject to a detailed evaluation by 5.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.14 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.3 and -$1.76 for the fiscal current year, implying an average EPS of -$1.49. EPS for the following year is -$1.01, with 5.0 analysts recommending between -$0.62 and -$1.35.
